| A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor W Wang, MB Boffa, L Bajzar, JB Walker, ME Nesheim Journal of Biological Chemistry 273 (42), 27176-27181, 1998 | 533 | 1998 |
| Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis M Nesheim, W Wang, M Boffa, M Nagashima, J Morser, L Bajzar Thrombosis and haemostasis 78 (07), 386-391, 1997 | 366 | 1997 |
| Lipoprotein (a) levels and the risk of myocardial infarction among 7 ethnic groups G Paré, A Çaku, M McQueen, SS Anand, E Enas, R Clarke, MB Boffa, ... Circulation 139 (12), 1472-1482, 2019 | 266 | 2019 |
| Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease? MB Boffa, ML Koschinsky Journal of lipid research 57 (5), 745-757, 2016 | 264 | 2016 |
| Plasma and recombinant thrombin-activable fibrinolysis inhibitor (TAFI) and activated TAFI compared with respect to glycosylation, thrombin/thrombomodulin-dependent activation … MB Boffa, W Wang, L Bajzar, ME Nesheim Journal of Biological Chemistry 273 (4), 2127-2135, 1998 | 261 | 1998 |
| Lipoprotein (a) catabolism is regulated by proprotein convertase subtilisin/kexin type 9 through the low density lipoprotein receptor R Romagnuolo, CA Scipione, MB Boffa, SM Marcovina, NG Seidah, ... Journal of Biological Chemistry 290 (18), 11649-11662, 2015 | 238 | 2015 |
| Determinants of binding of oxidized phospholipids on apolipoprotein (a) and lipoprotein (a) 1 G Leibundgut, C Scipione, H Yin, M Schneider, MB Boffa, S Green, ... Journal of lipid research 54 (10), 2815-2830, 2013 | 235 | 2013 |
| Two naturally occurring variants of TAFI (Thr-325 and Ile-325) differ substantially with respect to thermal stability and antifibrinolytic activity of the enzyme M Schneider, M Boffa, R Stewart, M Rahman, M Koschinsky, M Nesheim Journal of Biological Chemistry 277 (2), 1021-1030, 2002 | 233 | 2002 |
| Lipoprotein (a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models MB Boffa, SM Marcovina, ML Koschinsky Clinical biochemistry 37 (5), 333-343, 2004 | 222 | 2004 |
| Oxidized phospholipids as a unifying theory for lipoprotein (a) and cardiovascular disease MB Boffa, ML Koschinsky Nature Reviews Cardiology 16 (5), 305-318, 2019 | 203 | 2019 |
| Inhibition of plasminogen activation by lipoprotein (a): critical domains in apolipoprotein (a) and mechanism of inhibition on fibrin and degraded fibrin surfaces MA Hancock, MB Boffa, SM Marcovina, ME Nesheim, ML Koschinsky Journal of Biological Chemistry 278 (26), 23260-23269, 2003 | 185 | 2003 |
| A zebrafish retinoic acid receptor expressed in the regenerating caudal fin JA White, MB Boffa, B Jones, M Petkovich Development 120 (7), 1861-1872, 1994 | 174 | 1994 |
| Roles of thermal instability and proteolytic cleavage in regulation of activated thrombin-activable fibrinolysis inhibitor MB Boffa, R Bell, WK Stevens, ME Nesheim Journal of Biological Chemistry 275 (17), 12868-12878, 2000 | 171 | 2000 |
| Subclinical vitamin K deficiency in hemodialysis patients RM Pilkey, AR Morton, MB Boffa, C Noordhof, AG Day, Y Su, LM Miller, ... American journal of kidney diseases 49 (3), 432-439, 2007 | 164 | 2007 |
| A novel, possibly functional, single nucleotide polymorphism in the coding region of the thrombin-activatable fibrinolysis inhibitor (TAFI) gene is also associated … GJ Brouwers, HL Vos, FWG Leebeek, S Bulk, M Schneider, M Boffa, ... Blood, The Journal of the American Society of Hematology 98 (6), 1992-1993, 2001 | 163 | 2001 |
| Lipoprotein (a): more interesting than ever after 50 years JB Dubé, MB Boffa, RA Hegele, ML Koschinsky Current opinion in lipidology 23 (2), 133-140, 2012 | 153 | 2012 |
| Lipoprotein (a): a unique risk factor for cardiovascular disease E Anuurad, MB Boffa, ML Koschinsky, L Berglund Clinics in laboratory medicine 26 (4), 751-772, 2006 | 149 | 2006 |
| Characterization of the gene encoding human TAFI (thrombin-activable fibrinolysis inhibitor; plasma procarboxypeptidase B) MB Boffa, TS Reid, E Joo, ME Nesheim, ML Koschinsky Biochemistry 38 (20), 6547-6558, 1999 | 143 | 1999 |
| Curiouser and curiouser: recent advances in measurement of thrombin-activatable fibrinolysis inhibitor (TAFI) and in understanding its molecular genetics, gene regulation, and … MB Boffa, ML Koschinsky Clinical biochemistry 40 (7), 431-442, 2007 | 120 | 2007 |
| Mechanistic insights into Lp (a)-induced IL-8 expression: a role for oxidized phospholipid modification of apo (a) CA Scipione, SE Sayegh, R Romagnuolo, S Tsimikas, SM Marcovina, ... Journal of lipid research 56 (12), 2273-2285, 2015 | 111 | 2015 |
